Literature DB >> 20651371

CXCR4, a potential predictive marker for docetaxel sensitivity in gastric cancer.

Li Xie1, Jia Wei, Xiaoping Qian, Gang Chen, Lixia Yu, Yitao Ding, Baorui Liu.   

Abstract

UNLABELLED: The aim of this study was to explore predictive genes involved in docetaxel sensitivity of gastric cancer.
MATERIALS AND METHODS: Microarray analysis was performed to explore various gene expression levels between parental and docetaxel-resistant cells. A panel of 11 genes selected according to microarray analysis were validated and tested further in 11 cancer cell lines, resulting in 4 genes, CXCR4, CDK6, USP15 and CDH1. Histoculture drug response assay (HDRA) was used to examine docetaxel sensitivity, while qRT-PCR was used to measure the mRNA levels of the genes in 25 surgically dissected gastric cancer specimens.
RESULTS: Only CXCR4 mRNA levels in gastric cancer tissues were correlated with docetaxel sensitivity (R(2)=0.23, p=0.019) and significantly higher in resistant specimens (p=0.038). AMD3100, a CXCR4 antagonist, enhanced the docetaxel cytotoxicity in vitro.
CONCLUSION: CXCR4 mRNA expression levels may be a potential predictive biomarker in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651371

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

Review 1.  Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.

Authors:  Won-Tak Choi; Yilei Yang; Yan Xu; Jing An
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

2.  Combination of histoculture drug response assay and qPCR as an effective method to screen biomarkers for personalized chemotherapy in esophageal cancer.

Authors:  Bin Wei; Jiru Wang; Xiaohui Zhang; Zhaoye Qian; Jingjing Wu; Yuan Sun; Qin Han; Li Wan; Jing Zhu; Yong Gao; Xiaofei Chen
Journal:  Oncol Lett       Date:  2017-09-26       Impact factor: 2.967

Review 3.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

4.  USP15 negatively regulates Nrf2 through deubiquitination of Keap1.

Authors:  Nicole F Villeneuve; Wang Tian; Tongde Wu; Zheng Sun; Alexandria Lau; Eli Chapman; Deyu Fang; Donna D Zhang
Journal:  Mol Cell       Date:  2013-05-30       Impact factor: 17.970

Review 5.  The Multifaceted Roles of USP15 in Signal Transduction.

Authors:  Tanuza Das; Eun Joo Song; Eunice EunKyeong Kim
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

6.  CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling.

Authors:  A Dubrovska; A Hartung; L C Bouchez; J R Walker; V A Reddy; C Y Cho; P G Schultz
Journal:  Br J Cancer       Date:  2012-05-29       Impact factor: 7.640

7.  MicroRNAs miR-26a, miR-26b, and miR-29b accelerate osteogenic differentiation of unrestricted somatic stem cells from human cord blood.

Authors:  Hans-Ingo Trompeter; Janine Dreesen; Eugenie Hermann; Katharina M Iwaniuk; Markus Hafner; Neil Renwick; Thomas Tuschl; Peter Wernet
Journal:  BMC Genomics       Date:  2013-02-19       Impact factor: 3.969

8.  VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Authors:  Thomas Thomaidis; Annett Maderer; Salah-Eddin Al-Batran; Janis Kany; Claudia Pauligk; Kristina Steinmetz; Arno Schad; Ralf Hofheinz; Harald Schmalenberg; Nils Homann; Peter Robert Galle; Markus Moehler
Journal:  BMC Cancer       Date:  2014-07-01       Impact factor: 4.430

Review 9.  Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma.

Authors:  Li-Jun Xue; Xiao-Bei Mao; Li-Li Ren; Xiao-Yuan Chu
Journal:  Cancer Med       Date:  2017-05-23       Impact factor: 4.452

10.  Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer.

Authors:  Hongyong He; Cong Wang; Zhenbin Shen; Yong Fang; Xuefei Wang; Weidong Chen; Fenglin Liu; Xinyu Qin; Yihong Sun
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.